Literature DB >> 11042435

The role of cognition in vocational functioning in schizophrenia.

S R McGurk1, H Y Meltzer.   

Abstract

Schizophrenia is associated with long-term unemployment. Cognitive dysfunction, rather than clinical symptoms, may be the most important factor in the ability to work for patients with this disorder. To evaluate the relationship of clinical symptoms and cognitive functioning to work status, thirty patients with schizophrenia, who were participants in a vocational rehabilitation program, were evaluated with a comprehensive neuropsychological battery and assessment of psychopathology. Subjects were classified as being in stable full-time, part-time or unemployed work status for at least a year. Univariate analysis indicated that patients who were working full-time were significantly better educated, more likely to be treatment-resistant, more likely to be treated with an atypical antipsychotic medication, had more positive symptoms, and were engaged in work tasks which were more cognitively complex than the part-time employed and unemployed work groups. An ANCOVA controlling for education demonstrated that the full-time employed group performed significantly better than the unemployed group on measures of executive functioning, working memory and vigilance; and significantly better than the part-time group on measures of vigilance and executive functioning. Although negative symptoms did not significantly relate to work status in the univariate analysis, a multiple regression indicated that negative symptoms, level of education, and executive functioning differentiated the work groups. These results suggest that poor premorbid function, negative symptoms and cognitive dysfunction are significantly associated with unemployment in schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 11042435     DOI: 10.1016/s0920-9964(99)00198-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  76 in total

1.  Cognitive effects of olanzapine treatment in schizophrenia.

Authors:  Susan R McGurk; M A Lee; K Jayathilake; Herbert Y Meltzer
Journal:  MedGenMed       Date:  2004-05-10

2.  Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.

Authors:  Nurith Amitai; Athina Markou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

3.  Social/communication skills, cognition, and vocational functioning in schizophrenia.

Authors:  Dwight Dickinson; Alan S Bellack; James M Gold
Journal:  Schizophr Bull       Date:  2006-12-12       Impact factor: 9.306

Review 4.  [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].

Authors:  P Falkai; W Maier
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

5.  Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient?

Authors:  Matthew M Kurtz; James C Seltzer; Dana S Shagan; Warren R Thime; Bruce E Wexler
Journal:  Schizophr Res       Date:  2006-10-27       Impact factor: 4.939

6.  Factors associated with occupational and academic status in patients with first-episode psychosis with a particular focus on neurocognition.

Authors:  Marte Tandberg; Torill Ueland; Ole A Andreassen; Kjetil Sundet; Ingrid Melle
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-07       Impact factor: 4.328

7.  How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.

Authors:  John S Brekke; Maanse Hoe; Jeffrey Long; Michael F Green
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

Review 8.  [Cognitive disorders in schizophrenic patients].

Authors:  H-P Volz; F Reischies; M Riedel
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

9.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 10.  Refinement of diagnosis and disease classification in psychiatry.

Authors:  Yves Lecrubier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.